US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 25.230
  • -0.210-0.83%
Trading Apr 24 11:54 ET
2.17BMarket Cap-6387P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
41.65%242.16M
68.61%67.69M
47.29%62.27M
26.50%66.74M
27.05%45.46M
13.96%170.96M
-22.74%40.15M
-1.14%42.28M
74.89%52.76M
42.37%35.78M
Selling and administrative expenses
11.34%31.4M
27.16%8.84M
-7.71%7.02M
24.87%7.61M
5.05%7.93M
-1.79%28.2M
-27.99%6.96M
21.63%7.61M
-3.21%6.09M
15.95%7.55M
-General and administrative expense
11.34%31.4M
27.16%8.84M
-7.71%7.02M
24.87%7.61M
5.05%7.93M
-1.79%28.2M
-27.99%6.96M
21.63%7.61M
-3.21%6.09M
15.95%7.55M
Research and development costs
47.63%210.76M
77.29%58.84M
59.36%55.25M
26.71%59.13M
32.94%37.54M
17.68%142.76M
-21.54%33.19M
-5.04%34.67M
95.48%46.66M
51.60%28.24M
Operating profit
-41.65%-242.16M
-68.61%-67.69M
-47.29%-62.27M
-26.50%-66.74M
-27.05%-45.46M
-13.96%-170.96M
22.74%-40.15M
1.14%-42.28M
-74.89%-52.76M
-42.37%-35.78M
Net non-operating interest income expense
161.95%7.64M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
293.13%2.92M
637.36%1.34M
390.76%903K
110.00%441K
38.55%230K
Non-operating interest income
161.95%7.64M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
293.13%2.92M
637.36%1.34M
390.76%903K
110.00%441K
38.55%230K
Other net income (expense)
-2,522.22%-1.42M
-2,820.83%-701K
-1,300.00%-126K
-3,830.00%-373K
-620.00%-216K
-575.00%-54K
-24K
-9K
10K
-30K
Other non- operating income (expenses)
-2,522.22%-1.42M
-2,820.83%-701K
-1,300.00%-126K
-3,830.00%-373K
-620.00%-216K
-575.00%-54K
---24K
---9K
--10K
---30K
Income before tax
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
-42.51%-35.58M
Income tax
Net income
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
-42.51%-35.58M
Net income continuous Operations
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
-42.51%-35.58M
Minority interest income
Net income attributable to the parent company
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
-42.51%-35.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
2.81%-41.39M
-74.61%-52.3M
-42.51%-35.58M
Basic earnings per share
-22.29%-3.95
-47.30%-1.09
-23.75%-0.99
-6.93%-1.08
-13.04%-0.78
-10.24%-3.23
26.00%-0.74
3.61%-0.8
-74.14%-1.01
-38.00%-0.69
Diluted earnings per share
-22.29%-3.95
-47.30%-1.09
-23.75%-0.99
-6.93%-1.08
-13.04%-0.78
-10.24%-3.23
26.00%-0.74
3.61%-0.8
-74.14%-1.01
-38.00%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 41.65%242.16M68.61%67.69M47.29%62.27M26.50%66.74M27.05%45.46M13.96%170.96M-22.74%40.15M-1.14%42.28M74.89%52.76M42.37%35.78M
Selling and administrative expenses 11.34%31.4M27.16%8.84M-7.71%7.02M24.87%7.61M5.05%7.93M-1.79%28.2M-27.99%6.96M21.63%7.61M-3.21%6.09M15.95%7.55M
-General and administrative expense 11.34%31.4M27.16%8.84M-7.71%7.02M24.87%7.61M5.05%7.93M-1.79%28.2M-27.99%6.96M21.63%7.61M-3.21%6.09M15.95%7.55M
Research and development costs 47.63%210.76M77.29%58.84M59.36%55.25M26.71%59.13M32.94%37.54M17.68%142.76M-21.54%33.19M-5.04%34.67M95.48%46.66M51.60%28.24M
Operating profit -41.65%-242.16M-68.61%-67.69M-47.29%-62.27M-26.50%-66.74M-27.05%-45.46M-13.96%-170.96M22.74%-40.15M1.14%-42.28M-74.89%-52.76M-42.37%-35.78M
Net non-operating interest income expense 161.95%7.64M30.48%1.75M142.41%2.19M400.45%2.21M549.13%1.49M293.13%2.92M637.36%1.34M390.76%903K110.00%441K38.55%230K
Non-operating interest income 161.95%7.64M30.48%1.75M142.41%2.19M400.45%2.21M549.13%1.49M293.13%2.92M637.36%1.34M390.76%903K110.00%441K38.55%230K
Other net income (expense) -2,522.22%-1.42M-2,820.83%-701K-1,300.00%-126K-3,830.00%-373K-620.00%-216K-575.00%-54K-24K-9K10K-30K
Other non- operating income (expenses) -2,522.22%-1.42M-2,820.83%-701K-1,300.00%-126K-3,830.00%-373K-620.00%-216K-575.00%-54K---24K---9K--10K---30K
Income before tax -40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M-42.51%-35.58M
Income tax
Net income -40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M-42.51%-35.58M
Net income continuous Operations -40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M-42.51%-35.58M
Minority interest income
Net income attributable to the parent company -40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M-42.51%-35.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M2.81%-41.39M-74.61%-52.3M-42.51%-35.58M
Basic earnings per share -22.29%-3.95-47.30%-1.09-23.75%-0.99-6.93%-1.08-13.04%-0.78-10.24%-3.2326.00%-0.743.61%-0.8-74.14%-1.01-38.00%-0.69
Diluted earnings per share -22.29%-3.95-47.30%-1.09-23.75%-0.99-6.93%-1.08-13.04%-0.78-10.24%-3.2326.00%-0.743.61%-0.8-74.14%-1.01-38.00%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg